• About AMD

    • Kinds of AMD

  • AMD Warning Signs

  • Treating AMD

  • Visudyne

  • Support for Low Vision

  • Caregiving

  • Common Questions

  • Helpful Resources

  • Need a Specialist?
    • Click to find one
  • Experiencing Vision Loss?
    • Test for AMD now!
  • Financial Assistance
    • Click for access
    • English
    • Spanish
    • English
    • Spanish
Play

Age-related macular degeneration (AMD) is the leading cause of severe vision loss among older adults in the Western world. Yet only about 1 in 5 Americans knows about it.

AMD is a disease that damages the macula, the central portion of the area at the back of the eye called the retina. The macula allows for central vision and also lets you see color and fine detail—all of which are important to daily activities such as reading and driving.

Wet AMD is the most severe form of AMD

Wet AMD can progress quickly. If left uncontrolled, wet AMD can lead to permanent central vision loss.

Symptoms of wet AMD can include:

  • A spot or hazy section blocking the center of a scene
  • Distortion or waviness when looking at an image
  • Distortion of lines on the Amsler grid (a simple tool used by doctors and patients to detect early changes in vision)

Learn more

You are not alone
About 20 to 25 million people worldwide have AMD

Get checked
If you've been diagnosed with AMD, you need to be regularly monitored for changes in your eyes. So if you haven’t seen your ophthalmologist or retinal specialist recently, make an appointment today.

Is Visudyne for me?

Visudyne is a treatment to help slow the loss of vision in persons with predominantly classic wet AMD.

Important Safety Information

Visudyne therapy is not for everyone. People who have an abnormal sensitivity to light (a condition called porphyria) and those with allergies to any of the ingredients should not receive Visudyne. (Your doctor has a list of ingredients in Visudyne.) Check with your doctor or healthcare professional to see if you might be allergic to any component of Visudyne therapy. Only your doctor can determine if Visudyne is right for you.

Between 1% and 5% of patients experienced a substantial decrease in vision in the first 7 days after treatment, though some patients achieved partial recovery. Patients who experience substantial vision loss should consult their ophthalmologist or retinal specialist immediately. The most commonly reported adverse events (10-30%) were injection site reactions, temporary back pain during injection, changes in vision, including blurring, decreased sharpness in vision, and gaps in vision.

Patients should avoid direct sunlight or bright indoor light for 5 days following therapy with Visudyne.

Patients who have to go outdoors in daylight after treatment must protect all parts of their skin and eyes by wearing protective clothing and dark glasses. Ultraviolet (UV) sunscreens are not effective in protecting against photosensitivity reactions.